期刊
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
卷 30, 期 5, 页码 979-989出版社
SPRINGER
DOI: 10.1007/s10554-014-0419-7
关键词
Caffeine; Myocardial perfusion imaging; Pharmacologic stress; Regadenoson
资金
- Astellas Pharma Global Development, Inc.
- Astellas Scientific and Medical Affairs, Inc.
A multicenter, double-blind, randomized study was conducted to assess the effect of caffeine on regadenoson stress myocardial perfusion imaging (MPI). Subjects with a high likelihood of coronary artery disease underwent a rest single-photon emission computed tomography MPI on day 1 (MPI-1) and a stress MPI with regadenoson on day 3 (MPI-2). Individuals with a parts per thousand yen1 segment with a reversible defect received double-blind caffeine tablets (200 or 400 mg) or placebo 90 min before a repeat regadenoson stress MPI (MPI-3) on day 5. Overall, 207 subjects completed the study (caffeine 200 mg, n = 70; caffeine 400 mg, n = 71; placebo, n = 66). The mean number of segments with reversible defects decreased from MPI-2 to MPI-3 in the caffeine 200 and 400 mg groups versus no significant change in the placebo group [mean +/- A standard deviation: -0.61 +/- A 1.097, -0.62 +/- A 1.367, and 0.12 +/- A 0.981, respectively (overall treatment effect, P < 0.001)]. The majority of subjects who received caffeine shifted to a lower ischemia size category from MPI-2 to MPI-3, with no clear pattern observed in subjects who received placebo. For caffeine exposed patients with a parts per thousand yen3 segments with reversible defects at MPI-2, 21/23 had fewer detected at MPI-3. Both the 200 and 400 mg doses of caffeine significantly reduced the number of segments with reversible defects detected by regadenoson stress MPI.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据